Murcy, F., Borowczyk, C., Gourion-Arsiquaud, S., Torrino, S., Ouahrouche, N., Barouillet, T., Dussaud, S., Couralet, M., Vaillant, N., Merlin, J., Berquand, A., Kaikkonen, M. U., McClelland, R. L., Tressel, W., Stein, J., Thorp, E. B., Bertero, T., Barbry, P., Bailly-Maitre, B., … Yvan-Charvet, L. (2024). GLS2 links glutamine metabolism and atherosclerosis by remodeling artery walls. Nature Cardiovascular Research, 3(12), 1454–1467. https://doi.org/10.1038/s44161-024-00566-1

Fleischer, S., Nash, T. R., Tamargo, M. A., Lock, R. I., Venturini, G., Morsink, M., Graney, P. L., Li, V., Lamberti, M. J., Liberman, M., Kim, Y., Tavakol, D. N., Zhuang, R. Z., Whitehead, J., Friedman, R. A., Soni, R. K., Seidman, J. G., Seidman, C. E., Geraldino-Pardilla, L., … Vunjak-Novakovic, G. (2024). An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Nature Cardiovascular Research, 3(9), 1123–1139. https://doi.org/10.1038/s44161-024-00525-w

Tall, A. R., & Fidler, T. P. (2024). An epigenetic switch in macrophages promotes fibrosis in the failing heart. Nature Cardiovascular Research, 3(3), 254–255. https://doi.org/10.1038/s44161-024-00439-7

Fidler, T. P., Dunbar, A., Kim, E., Hardaway, B., Pauli, J., Xue, C., Abramowicz, S., Xiao, T., O’Connor, K., Sachs, N., Wang, N., Maegdefessel, L., Levine, R., Reilly, M., & Tall, A. R. (2024). Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis. Nature Cardiovascular Research, 3(1), 60–75. https://doi.org/10.1038/s44161-023-00405-9

de Vries, P. S., Conomos, M. P., Singh, K., Nicholson, C. J., Jain, D., Hasbani, N. R., Jiang, W., Lee, S., Lino Cardenas, C. L., Lutz, S. M., Wong, D., Guo, X., Yao, J., Young, E. P., Tcheandjieu, C., Hilliard, A. T., Bis, J. C., Bielak, L. F., Brown, M. R., … Malhotra, R. (2023). Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification. Nature Cardiovascular Research, 2(12), 1159–1172. https://doi.org/10.1038/s44161-023-00375-y

Liu, W., Yalcinkaya, M., Maestre, I. F., Olszewska, M., Ampomah, P. B., Heimlich, J. B., Wang, R., Vela, P. S., Xiao, T., Bick, A. G., Levine, R., Papapetrou, E. P., Libby, P., Tabas, I., Wang, N., & Tall, A. R. (2023). Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis. Nature Cardiovascular Research, 2(6), 572–586. https://doi.org/10.1038/s44161-023-00281-3

Bashore, A. C., Zhu, L. Y., & Reilly, M. P. (2022). A new era in understanding atherosclerotic plaques. Nature Cardiovascular Research, 1(12), 1127–1129. https://doi.org/10.1038/s44161-022-00187-6

Kronish, I. M., & Shechter, A. (2022). COVID-19 and the amplification of cardiovascular risk by psychological distress. Nature Cardiovascular Research, 1(11), 968–970. https://doi.org/10.1038/s44161-022-00153-2

Papa, A., Zakharov, S. I., Katchman, A. N., Kushner, J. S., Chen, B., Yang, L., Liu, G., Jimenez, A. S., Eisert, R. J., Bradshaw, G. A., Dun, W., Ali, S. R., Rodriques, A., Zhou, K., Topkara, V., Yang, M., Morrow, J. P., Tsai, E. J., Karlin, A., … Marx, S. O. (2022). Rad regulation of CaV1.2 channels controls cardiac fight-or-flight response. Nature Cardiovascular Research, 1(11), 1022–1038. https://doi.org/10.1038/s44161-022-00157-y

Chakouri, N., Rivas, S., Roybal, D., Yang, L., Diaz, J., Hsu, A. L., Mahling, R., Chen, B.-X., Owoyemi, J. O., DiSilvestre, D., Sirabella, D., Corneo, B., Tomaselli, G. F., Dick, I. E., Marx, S. O., & Ben-Johny, M. (2022). Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium current. Nature Cardiovascular Research, 1(5), 1–13. https://doi.org/10.1038/s44161-022-00060-6

Tall, A. R., & Wang, N. (2022). New insights into cholesterol efflux via ABCA1. Nature Cardiovascular Research, 1(3), 198–199. https://doi.org/10.1038/s44161-022-00036-6

Song, L., Bekdash, R., Morikawa, K., Quejada, J. R., Klein, A. D., Aina-Badejo, D., Yoshida, K., Yamamoto, H. E., Chalan, A., Yang, R., Patel, A., Sirabella, D., Lee, T. M., Joseph, L. C., Kawano, F., Warren, J. S., Soni, R. K., Morrow, J. P., & Yazawa, M. (2022). Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome. Nature Cardiovascular Research, 1(2), 142–156. https://doi.org/10.1038/s44161-021-00016-2